St. Jude Medical Wins European Approval for Prodigy System

St. Jude Medical (NYSE: STJ  ) has launched its latest product on the European market. The company announced that it has received the CE Mark for its Prodigy Chronic Pain System with Burst Technology and can now market and sell the product on the continent.

St. Jude Medical claims that Prodigy is "the first and only implantable neuromodulation system that delivers burst stimulation." It is intended to reduce pain and reduce parasthesia, a tingling sensation, in patients suffering from chronic pain. It utilizes spinal cord stimulation to achieve its effects.

In the press release announcing the news, the company quoted its Group President Eric Fain as saying that Prodigy "is a great example of our approach for innovative and alternative ways to provide relief to patients suffering from chronic pain, including those who have exhausted other treatment options or who may have lost effective therapy using traditional tonic stimulation."


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2884156, ~/Articles/ArticleHandler.aspx, 10/2/2014 6:41:08 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement